SOLUX, has evolved into a specialty pharmaceutical company, focusing on developing, manufacturing and marketing of brand and generic pharmaceutical products by utilizing various drug delivery technologies.

SOLUX exclusive partners manufacture and distribute high-quality pharmaceuticals according to GMP requirements and regulations.

SOLUX exclusive partners activities include manufacturing, promoting, and distributing different kinds of pharmaceutical specialties.
We constantly expand our product line by establishing new collaborations with multinational pharmaceutical companies.

Since 1992, SOLUX partner has been manufacturing and distributing Under-license products from some of the world's most ethical and recognized companies such as BRISTOL-MYERS SQUIBB and ELI LILLY.

Our partner is registered as a quality assured firm through the achievement of ISO 9002 certificate.

Mission Statement
We shall strive to always provide the highest quality medicine for all and maintain a leading position in the local and international markets through continuously improving our knowledge, production capabilities, and the global market needs. We rely on the highest quality standards in achieving all of our goals. OEM Service:
No. of R&D Staff:
Estimated Annual Sales (USD): US$1 Million - US$2.5 Million
Export Percentage:
Quality Control:
Legal Representative/CEO:
Factory Size (Sq.meters):
Factory Location:
Corporate Status:

Business Type: Year Established: 2003 Number of Employees: Legal Representative / CEO: Dr Dominique Pinault Website: Certificates: Brands: Trade & Market Main Markets: Main Customers: Export Percentage: Trade Shows: Factory Information Factory Size (Sq.meters): Factory Location: QA/QC: Number of Production Lines: Number of R&D Staff: Contract Manufacturing: